Recombinant protein

The present invention relates to a recombinant protein, and in particular relates to a highly glycosylated erythropoietin (EPO) with a longer half-life. The highly glycosylated peptide can be located on the N-terminal end (N-ter) or carboxy-terminal end (C-ter) of the EPO.

*This invention has been granted in United States, Canada, Taiwan, China, Japan, South Korea, Europe, Hong Kong, Malaysia, Singapore, Australia, and New Zealand.

Plasmid construction